| 证券代码 | BDSI.O |
| 证券名称 | BioDelivery Sciences International Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2002-07-25 |
| 首发价格(元) | 5.25 |
| 首发数量(股) | 2000000 |
| 首发募资额(元) | 10,500,000.00 |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | BioDelivery Sciences International, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 4131 ParkLake Avenue, Suite 225, Raleigh, North Carolina, USA |
| 成立日期 | 1997-01 |
| 董事会主席 | Peter S. Greenleaf |
| 公司属地 | United States 美国 |
| 公司网址 | www.bdsi.com |
| 电话 | +1 (919) 582-9050 |
| 传真 | +1 (919) 582-9051 |
| 公司简介 | BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is developing and commercializing, either on its own or in partnership with third parties, new applications of approved therapeutics to address important unmet medical needs using both proven and new drug delivery technologies. The company has developed and are continuing to develop pharmaceutical products aimed principally in the areas of pain management and addiction. The company was incorporated in the State of Indiana in 1997 and were reincorporated as a Delaware corporation in 2002. |